Publications

Quarterly summary of recent safety communications

Published 2 June 2022
Prescriber Update 43(2): 18
June 2022

The table below is a summary of recent safety communications to health care professionals and consumers, published on the Medsafe website.

Date	Communication	Topic
10/05/2022	Dear Healthcare Professional Letter	Change in appearance of Motetis 25 mg tablets (PDF, 169 KB, 1 page)
08/04/2022	Alert	Reminder: Miracle Mineral Solution has dangerous and potentially life-threatening side effects
05/04/2022	Dear Healthcare Professional Letter	Supply of PAXLOVID (nirmatrelvir 150 mg/ritonavir 100 mg), film coated tablets (PDF, 292 KB, 5 pages)
29/03/2022	Dear Healthcare Professional Letter	New improvements occurring on the ClopineCENTRAL™ website (PDF, 168 KB, 2 pages)
03/03/2022	Information leaflet	Risks of opioid medicines (PDF, 320 KB, 2 pages)
24/02/2022	Dear Healthcare Professional Letter	Supply of Nuvaxovid COVID-19 vaccine in New Zealand (PDF, 222 KB, 1 page)
22/02/2022	Monitoring	Possible risk of vasculitis with vildagliptin products (Galvus, Galvumet)